Download fulltext pdf download fulltext pdf craniopharyngioma in adults article pdf available in frontiers in endocrinology 3. Craniopharyngioma cp adherence represents a most baffling problem for the neurosurgeon. This tumor most commonly affects children between 5 and 10 years of age. On the one hand, they are curable after total removal. The two variants of craniopharyngioma are histologically, and as will be discussed later in the chapter, molecularly distinct. The ucla pituitary tumor program has experts in each of the specialties, working closely together to provide you with the most comprehensive, stateoftheart surgical and nonsurgical treatments. Across all ages, craniopharyngiomas constitute only around 1% of all the new central.
Different types of treatments are available for children with craniopharyngioma. The papillary variety, with the exception of rare pediatric cases accounting for up to 2% in this age group 41, 42, 46, has been almost exclusively described in adult populations accounting for 1450% in this age group 44, 45. On initial exam, the patient was neurologically intact and without headache. Craniopharyngiomas are very rare benign noncancerous tumours, with 50% occurring in children under 16 years, and the remainder at any time in adult life. Craniopharyngiomas are benign tumors that occur at the base of the brain, above the. Adamantinomatous and papillary craniopharyngiomas are. Social and psychointellectual outcome following radical removal of. Table 1 a selected overview on results of surgery for craniopharyngioma. Craniopharyngioma genetic and rare diseases information. These tumors are typically composed of a solid portion formed by nests and trabeculae of epithelial tumor cells, with an abundance of calcification, and a cystic component that is filled with a dark, oily fluid. Treatment options for pediatric craniopharyngioma surgical. Craniopharyngiomas are divided in two main histological subtypes, the adamantinomatous and the papillary type, but transitional and mixed variants have also been reported weiner et al.
However, as they grow they may put pressure on nearby brain regions, like the pituitary, hypothalamus, optic nerves, and the fluidfilled ventricles of the brain. During adulthood there is a peak incidence between 40 and 44 years. Nineteen patients with the diagnosis of cystic craniopharyngioma were treated with intratumoral chemotherapy with interferon alpha from january 2002. Craniopharyngioma was the name introduced by cushing for tumors derived from epithelial rests ascribable to an imperfect closure of the hypophysial or craniopharyngeal duct. Craniopharyngiomas cps are one of the most frustrating tumors in pediatric neurosurgery. After extensive discussion of the risks, benefits, and alternatives to surgery, a right frontal endoscopic transventricular resection was planned with. Craniopharyngioma an overview sciencedirect topics. The tumours can be solid, cystic full of fluid, calcified, or full of debris. The pathogenesis of craniopharyngioma is currently debated between two primary hypotheses. Frontiers craniopharyngioma in adults endocrinology. Atlas of craniopharyngioma pathology, classification and surgery. Clinical trials are used for all types of craniopharyngioma. Brain tumours primary and brain metastases in adults the national institute for health and care excellence nice, july 2018. There is a significant differential diagnosis that must be considered.
Craniopharyngiomas are rare tumors, with an estimated incidence of 231 million. Craniopharyngiomas are benign tumors that occur at the base of the brain, above the pituitary gland. They are most common in children age 515 years old and older adults 6070 years of age. Craniopharyngioma brain and spinal cord tumours cancer. Symptoms and signs of the tumor are often the result of the close anatomical proximity to the hypothalamus, the ventricular system, and the optic chiasm. It is characterized by headache, nausea, vomiting especially in the morning, and difficulty with balance. Affected populations craniopharyngiomas occur in around 0.
As a craniopharyngioma slowly grows, it can affect the function of the pituitary gland and other nearby structures in the brain. Hankinson and others published craniopharyngioma find, read and cite all the research you need on researchgate. This stateoftheart, minimally invasive approach allows surgeons to access the tumor through the natural corridor of the nose, without making an open. In the united states, an estimated 350 new cases of craniopharyngioma are diagnosed each year.
This tumor also appears in older age groups, and almost 60% of the cases are found in adults 2. Interhemispheric transcallosal transforaminal approach and. Greg james, kristian aquilina, in principles of neurological surgery fourth edition, 2018. The basal layer of the epithelium is composed of a compact. Detection of tumorspecific signaling pathway activation enables the possibility of targetoriented intervention. A yearold female with intermittent headaches evaluated by an ophthalmologist was noted to have a retinal abnormality, prompting a magnetic resonance imaging mri scan and referral to the neurosurgery service. Craniopharyngioma treatments minimally invasive surgery. Pituitary necrosis and vasospasm following removal of. Hypothalamic obesity in craniopharyngioma patients. The adamantinomatous type is composed of nests and trabeculae of epithelium that are usually embedded within gliotic adjacent brain tissue asa, 1997, rushing et al. There are controversial hypotheses on its embryonal origin.
Inroduction frequency pathology clinical presentation 3. Craniopharyngioma is a rare, nonglial, nonmalignant intracranial tumor derived from a malformation of embryonal tissue. Its cellular structure resembles the oropharyngeal mucosa, and although its origin remains unclear, it may represent the one extreme of a spectrum of. Surgery is the primary treatment for craniopharyngiomas. Craniopharyngioma begins near the brains pituitary gland, which secretes hormones that control many body functions. It covers histoembryology of craniopharyngioma, together with anatomical. Craniopharyngioma is a benign tumor typically treated with both surgery and radiation, an approach that offers 5year progressionfree survival pfs rates exceeding 90% 1.
Craniopharyngioma is a rare type of brain tumor that mostly affects children between the ages of 5 and 14. Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. Some treatments are standard the currently used treatment, and some are being tested in clinical trials. Craniopharyngiomas of the skull base may be approached directly using the endoscopic endonasal approach eea.
There are different types of treatment for children with craniopharyngioma. However, radiation treatment instead of surgery may be the best choice for some patients. Craniopharyngioma nord national organization for rare. Craniopharyngiomas constitute approximately 1 to 3 percent of all brain tumors 2,3 and approximately 5 to 10 percent of brain tumors in children 3,4. People may present with bitemporal inferior quadrantanopia. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. Adamantinomatous craniopharyngioma is the type found most frequently in children. The highest priority of current surgical treatment is to maximize tumor removal without compromising the. A craniopharyngioma is a rare type of brain tumor derived from pituitary gland embryonic tissue that occurs most commonly in children, but also affects adults. Surgery has been the main treatment for craniopharyngioma. Craniopharyngiomas are present with a wide range of appearances, but the existence of cysts, calcification, and enhancement in a suprasellar tumor strongly favors the diagnosis. Alternatively, you can download the file locally and open with any standalone pdf reader.
The radiographic findings were suggestive of craniopharyngioma. Craniopharyngiomas are rare malformational tumours of low histological malignancy arising along the craniopharyngeal duct. Craniopharyngioma surgical series comparing the degree of removal and outcome between primary and recurrent cases. There are two histopathological types, the adamantinomatous and the papillary type. Craniopharyngiomas are slow growing benign tumors of the sellar and parasellar region with an overall incidence rate of approximately 1. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new. The adamantinomatous type may develop at all ages, whereas the papillary type almost exclusively. Craniopharyngioma bmj best practice, last accessed january 2019. Despite its histologic appearance, craniopharyngiomas occasionally behave like malignant tumors. The onset of symptoms is normally insidious with most patients at diagnosis having neurological headaches, visual disturbances and endocrine growth. They grow near the pituitary gland at the base of the. Postoperative prognosis in craniopharyngioma with respect.
Craniopharyngioma is a slowgrowing, noncancerous brain tumor that. In tumors that cannot be removed completely with surgery alone, radiation therapy is usually necessary. Diagnostics, treatment, and followup in craniopharyngioma. A craniopharyngioma is a benign tumor that develops near the pituitary gland a small endocrine gland at the base of the brain. These types of studies evaluate new drugs, different combinations of treatments, new approaches to radiation therapy or surgery, and new methods of treatment.
Craniopharyngioma accounts for up to 10% of all intracranial tumors in children. It may present at any age, even in the prenatal and neonatal periods, but peak incidence rates are childhoodonset at 514 years and adultonset at 5074 years. Craniopharyngioma is a slowgrowing, noncancerous brain tumor that develops near the pituitary gland a small endocrine gland at the base of the brain which produces several important hormones and the hypothalamus an endocrine organ which controls the release of hormones by the pituitary gland. The survival rate for childhood craniopharyngioma has been improving with more longterm survivors. Ppt craniopharyngioma powerpoint presentation free to.
Typically, a medical team, combining specialists from many disciplines, will manage your treatment. Historically, these high tumor control rates have come at the cost of longterm side effects, such as endocrinopathy, hypothalamic dysfunction, visual field deficits. Craniopharyngioma orphanet journal of rare diseases. Many focus on new treatments to learn if a new treatment is safe, effective, and possibly better than the existing treatments. Craniopharyngioma is the most common lesion of the hypothalamic and suprasellar region in childhood with a frequent compromised pituitary. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a pdf plugin installed and enabled in your browser. As such, the ideal treatment of craniopharyngiomas should be complete resection, which might be expected to result in a cure. They can metastasize, and patients can have severe symptoms that usually require surgery andor. The differential diagnosis for craniopharyngioma can include a variety of entities, including pituitary macroadenoma, metastasis, rathkes cleft cyst, colloid cyst.
As for adamantinomatous craniopharyngioma, the exact cause of development of papillary craniopharyngioma is unknown. The two histological subtypes, adamantinomatous craniopharyngioma acp. Craniopharyngioma is a rare type of noncancerous benign brain tumor. The point prevalence of this tumour is approximately 2100,000.
838 892 1013 1307 1055 831 690 1234 1547 34 34 145 607 978 426 328 621 191 1311 1287 167 1242 1138 829 617 429 1004 883 838 594 678 234 55 968 470 1069